Journal profile · Medicine-Pulmonary and Respiratory Medicine
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
ISSN 2405-5794 · Elsevier · United Kingdom
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.3 (journal website); fully open access; APC about USD 2,660; review about 30 weeks (community reports); 68 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tuberculosis Research and Epidemiology, Diagnosis and treatment of tuberculosis and Mycobacterium research and diagnosis, together about 59.8% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (JCTUBE) is an Open Access publication.JCTUBE provides a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections. We seek to publish articles that advance global epidemiologic understanding—including the intersection with other medical co-morbidities and socioeconomic conditions, clinical diagnosis, treatment, and prevention of tuberculosis and other mycobacterial diseases. We prioritize studies that will impact and drive changes in public health and clinical management of tuberculosis and non-tuberculous mycobacterial infection.The journal publishes a broad range of topics related to tuberculosis and other mycobacterial diseases, including:EpidemiologySociologyTransmissionDiagnosisTreatmentDrug resistancePublic health and policyWe seek review articles, editorials and commentaries on recent literature that challenge current thinking and advance clinical practice.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pulmonary and Respiratory Medicine
Editor-in-chief James T. GaensbauerPublisher website
Editorial board by country: 6 in mainland China (about 17%); most named United States 19, Mainland China 6, India 5, Italy 2, Canada 2 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tuberculosis Research and EpidemiologyMedicine35%
- Diagnosis and treatment of tuberculosisMedicine12.8%
- Mycobacterium research and diagnosisMedicine12.1%
- Infectious Diseases and TuberculosisMedicine10.7%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine5.7%
- Pneumonia and Respiratory InfectionsMedicine3.7%
- Diverse Scientific Research StudiesHealth Professions2.8%
- Infectious Diseases and MycologyVeterinary2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 3.7LetPub ·
- CiteScore (publisher)
- 3.7Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 1.25LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 222OpenAlex ·
- 2-year mean citedness
- 2.37OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 58LetPub ·
Articles by year OpenAlex count · 641 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 65 | 65 | 10 |
| 2025 | 68 | 68 | 172 |
| 2024 | 90 | 90 | 346 |
| 2023 | 69 | 69 | 599 |
| 2022 | 50 | 50 | 575 |
| 2021 | 82 | 82 | 1,159 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 30 weeksLetPub ·
- Submission to publication (journal-reported)
- about 21 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,660 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,470 / EUR 2,310 / GBP 1,980 / JPY 306,350 | — | — | |
| LetPub | USD 1,860 | Yes | — | |
| Publisher website | USD 2,870 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Cover letter
- Required
Article types accepted11
- case report1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- commentary1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- editorial1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- how i treat6. How I Treat Limit authorship to a maximum of 2 authors Maximum words 4,000 words Maximum of 5 tables and figures Up to 70 referencesLength not stated
- letter1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- letter to the editor5. Letter to the Editor Comment on recently published JCTUBE articles Maximum words: 1,000 Maximum of 1 table and figure Up to 5 referencesLength not stated
- original research1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- original research article1. Original Research Article Maximum words: 3000 Maximum of five (5) tables and figures Up to 40 references.Length not stated
- perspective1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- review1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
- systematic review1. Original Research ArticleMaximum words: 3000Maximum of five (5) tables and figuresUp to 40 references.2. Review (pre-enquiry required prior to submission*)Ma…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2405-5794
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
What CAS zone is Journal of Clinical Tuberculosis and Other Mycobacterial Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Microbiology / Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical Tuberculosis and Other Mycobacterial Diseases?
The journal's website gives an impact factor of 2.3; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.7, h-index 39.
How long does peer review take at Journal of Clinical Tuberculosis and Other Mycobacterial Diseases?
Authors report an average review time of about 30 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Clinical Tuberculosis and Other Mycobacterial Diseases?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Clinical Tuberculosis and Other Mycobacterial Diseases based?
Of the 36 board members whose country the journal's board page names, 6 (about 17%) are in mainland China; the countries named most often are United States (19), Mainland China (6) and India (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Clinical Tuberculosis and Other Mycobacterial Diseases?
According to LetPub and DOAJ records, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is indexed in ESCI, Scopus and DOAJ.
Is Journal of Clinical Tuberculosis and Other Mycobacterial Diseases open access, and what is the APC?
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is a fully open-access journal. APC about USD 2,660.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .